The BioCanRx network is changing the face of cancer treatment

 

BioCanRx’s vision is to cure patients and enhance the quality of life of those living with cancer. We will do this by supporting world-class research in the area of immune oncology, and by accelerating to the clinic the most promising cancer immunotherapies designed to save lives and enable a better quality of life. Through an innovative, collaborative funding process BioCanRx is becoming a world-leader in the translation, manufacture and adoption of leading edge cancer immunotherapy treatments for the benefit of cancer patients.

 

 

for-resesarchers-1
for-resesarchers-1
for-resesarchers-1
for-resesarchers-1

 

 

 


Giving melanoma the one-two punch

 

Melanoma is a much more serious cancer, harder to treat and tends to progress more quickly. In 2017 alone, 7,300 people in Canada were diagnosed with melanoma; 1,240 died from it.

 

Learn more →


World Cancer Day 2019

 

On February 4th, BioCanRx is proud to take part in this global initiative aimed at making a commitment to a world without cancer. Across the country, the BioCanRx network is accelerating to the clinic Canada’s most promising and innovative cancer immunotherapies designed to save lives and enable a better quality of life.

 

Learn more →


Matchmaker, matchmaker, make me a match…

 

Jonathan Bramson’s lab at McMaster University had developed a new technology to produce immune cells that will attack multiple myeloma cells. Jean-Sébastien Delisle’s lab at the Université de Montréal had novel methods and capacity to manufacture human immune cells that target cancer cells and that persist for a long time in the body, providing sustained anti-cancer activity.

 

Learn more →

 

 

Summit for Cancer Immunotherapy

VICTORIA, B.C.
summitforcancer
Join the BioCanRx Network at the 4th annual Summit for Cancer Immunotherapy (Summit4CI) taking place in Victoria!

October 20-23, 2019

Fairmont Empress Hotel

Learn More Sponsorship Opportunities
Learning Institute Community Dissemination Report 2018

The participants of the 2018 BioCanRx-Cancer Stakeholder Alliance Learning Institute wish to share their Community Dissemination Report with the oncology patient and researcher community, BioCanRx, the Cancer Stakeholder Alliance, and the general public.

Click here for the full report
For the latest BioCanRx news and network activities:

Subscribe to our newsletter and email updates Subscribe
Follow us on Twitter
Like us on Facebook
Follow us on Instagram Follow
Subscribe to us on Youtube  Subscribe
Follow us on LinkedIn Follow

 

Our Network Members